SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Referencias del artŪculo

PUERRO VICENTE, M.; GARCIA LUQUE, A.; SANCHEZ LOPEZ, P. ¬†y¬† CABANES MARISCAL, M.A.. Evaluaci√≥n positiva de medicamentos: 4¬ļ Trimestre 2011. Sanid. Mil. [online]. 2012, vol.68, n.1, pp.44-46. ISSN 1887-8571.¬† http://dx.doi.org/10.4321/S1887-85712012000100009.

    1. Agencia Española de Medicamentos y Productos Sanitarios. Informe mensual sobre Medicamentos de Uso Humano y Productos Sanitarios Octubre 2011. Disponible en: http://www.aemps.gob.es/informa/informeMensual/2011/octubre/home.htm [ Links ]

    2. Dirschka T, Radny P, Dominicus R, Mensing H, BrŁning H, Jenne L, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol. 2012 Jan;166(1):137-146. [ Links ]

    3. Szeimies RM, Radny P, Sebastian M, Borrosch F, Dirschka T, Krähn-Senftleben G, Reich K, et al. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. Br J Dermatol. 2010 Aug;163(2):386-94. [ Links ]

    4. Committee for Medicinal Products for Human Use (CHMP). Ameluz. Disponible en: http://www.ema.europa.eu/ema/index.jsp? curl=pages/medicines/human/medicines/002204/smops/Positive/human_smop_000298.jsp&mid=WC0b01ac058001d127 &source=homeMedSearch&category=human. [ Links ]

    5. Bilton D, Robinson P, Cooper P, Gallagher CG, Kolbe J, Fox H, et al. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study. Eur Respir J. 2011 Nov;38(5):1071-80. [ Links ]

    6. Jaques A, Daviskas E, Turton JA, McKay K, Cooper P, Stirling RG, et al. Inhaled mannitol improves lung function in cystic fibrosis. Chest. 2008 Jun;133(6):1388-96. [ Links ]

    7. Committee for Medicinal Products for Human Use (CHMP). Bronchitol. Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001252/smops/Positive/human_smop_000304.jsp&mid=WC0b01ac058001d127 [ Links ]

    8. Agencia Española de Medicamentos y Productos Sanitarios. Informe mensual sobre Medicamentos de Uso Humano y Productos Sanitarios Diciembre 2011. Disponible en: http://www.aemps.gob.es/informa/informeMensual/2011/diciembre/home.htm [ Links ]

    9. Levens ED, Potlog-Nahari C, Armstrong AY, Wesley R, Premkumar A, Blithe DL, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol 2008;111:1129-36. [ Links ]

    10. Nieman LK, Blocker W, Nansel T, Mahoney S, Reynolds J, Blithe D, et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebocontrolled, phase IIb study. Fertil Steril 2011;95:767-72.e1-2. [ Links ]

    11. Agencia Española de Medicamentos y Productos Sanitarios. Informe mensual sobre Medicamentos de Uso Humano y Productos Sanitarios Noviembre 2011. Disponible en: http://www.aemps.gob.es/informa/informeMensual/2011/noviembre/home.htm [ Links ]

    12. Wells SA, Robinson BG, Gagel RF, et al. Vandetanib in locally advanced or metastatic medullary thyroid cancer: a randomized double blind Phase III trial (ZETA) (abstract). J Clin Oncol. 2010;28(15 Suppl): Abst 5503. [ Links ]

    13. Committee for Medicinal Products for Human Use (CHMP). Caprelsa. Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002315/smops/Positive/human_smop_000299.jsp&mid=WC0b01ac058001d127. [ Links ]

    14. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. New Engl J Med. 2011; 364(26):2507-16. [ Links ]

    15. Committee for Medicinal Products for Human Use (CHMP). Zelboraf. Disponible en: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/12/news_detail_001412.jsp&mid=WC0b01ac058004d5c1 [ Links ]